Breaking News

Waters Corp. Acquires Technology & IP of Megadalton Solutions

Megadalton’s CDMS technology will be further developed to extend the capabilities of Waters’ mass spectrometry portfolio.

Author Image

By: Charlie Sternberg

Associate Editor

Waters Corporation has acquired the technology assets and intellectual property rights of Megadalton Solutions Inc., an early-stage developer of Charge Detection Mass Spectrometry (CDMS) technology and services.   Founded in 2018 by professors Martin Jarrold and David Clemmer at Indiana University, Megadalton Solutions has developed CDMS instrumentation that makes it possible to analyze extremely large proteins and protein complexes, such as those used in cell and gene therapies, that would ot...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters